Use of rituximab in combination with high-dose methotrexate in the treatment of primary central nervous system lymphoma in a mycophenolate mofetil treated patient with lupus nephritis

By Lai Gillianne Geet Yi   Koo Yu Xuan   Tao Miriam   Tan Thuan Tong   Lim Soon-Thye  

Acta Oncologica, Vol. 50, Iss. 1, 2011-01 ,pp. : 144-145

Informa Healthcare

Access to resources Recommend Favorite

Methotrexate re-challenge for recurrent primary central nervous system lymphoma

By Pentsova Elena   DeAngelis Lisa   Omuro Antonio  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 161-165

Springer Publishing Company

Access to resources Recommend Favorite

Expression of signal transducer and activator of transcription 3 (STAT3) in primary central nervous system diffuse large B-cell lymphoma: a retrospective analysis of 17 cases

By Vajpayee Neerja   Hussain Juhi   Tolocica Ioana   Hutchison Robert   Gajra Ajeet  

Journal of Neuro-Oncology, Vol. 100, Iss. 2, 2010-11 ,pp. : 249-253

Springer Publishing Company

Access to resources Recommend Favorite

Immunohistological profiling by B-cell differentiation status of primary central nervous system lymphoma treated by high-dose methotrexate chemotherapy

By Kinoshita Manabu   Hashimoto Naoya   Izumoto Shuichi   Okita Yoshiko   Kagawa Naoki   Maruno Motohiko   Ohnishi Takanori   Arita Norio   Yoshimine Toshiki  

Journal of Neuro-Oncology, Vol. 99, Iss. 1, 2010-08 ,pp. : 95-101

Springer Publishing Company

Access to resources Recommend Favorite

Methotrexate based chemotherapy and deferred radiotherapy for primary central nervous system lymphoma (PCNSL): single institution experience

By Silvani A.   Salmaggi A.   Eoli M.   Lamperti E.   Broggi G.   Marras C.   Fariselli L.   Milanesi I.   Fiumani A.   Gaviani P.   Erbetta A.   Giovagnoli A.   Pollo B.   Botturi A.   Boiardi A.  

Journal of Neuro-Oncology, Vol. 82, Iss. 3, 2007-05 ,pp. : 273-279

Springer Publishing Company

Access to resources Recommend Favorite